Capricor Board Shakeup
Kaos Capital Plans to Nominate Two Independent Directors to Capricor Therapeutics Board
Kaos Capital, a significant shareholder in Capricor Therapeutics (NASDAQ: CAPR), is pushing for major board changes at the biotech company. The investment firm plans to nominate two independent directors and is calling on other shareholders to demand an immediate board meeting Benzinga.
Kaos Capital is also urging the board to adopt a cash preservation plan. This plan would freeze nonessential spending and conduct a zero-based review of general and administrative costs Calgary Herald. The company reported $237.9 million in cash and marketable securities as of June 30 PR Record Gazette.
Activist Investor Demands Board Overhaul
Kaos Capital has issued a letter to Capricor shareholders outlining its concerns Leader Post. The firm wants immediate governance changes at the struggling biotech company. Two new independent directors are central to the activist push.
The nomination represents a challenge to current board leadership. Kaos Capital believes fresh perspectives are needed to guide the company forward. The firm has gathered support from other shareholders for its campaign Montreal Gazette.
Cash Preservation Plan Targets Spending Cuts
Beyond board seats, Kaos Capital wants operational changes immediately. The cash preservation plan calls for a near-term freeze on nonessential spending. A zero-based review of G&A expenses would examine every dollar the company spends Calgary Herald.
Capricor has substantial cash reserves to protect. With $237.9 million in liquid assets, the company has runway for its operations Recorder. Kaos Capital argues these funds must be managed more carefully going forward.
Shareholder Pressure Mounts on Capricor Leadership
The activist campaign represents a critical moment for Capricor Therapeutics. Kaos Capital is leveraging its significant shareholding to force change. The firm has called on other investors to join its effort at the shareholder meeting Leader Post.
Board resistance to these demands remains unclear. But Kaos Capital's specific proposals—two new directors plus spending controls—give shareholders concrete options to vote on. The upcoming meeting will determine if the activist firm succeeds in reshaping the company's direction Benzinga.
Sentiment
NeutralPublishers
6
Articles
5
Reach
6
